About: Pergolide Mesylate     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : owl:Class, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
rdfs:label
  • Pergolide Mesylate
rdfs:subClassOf
Has_Free_Acid_Or_Base_Form
Concept_In_Subset
Semantic_Type
  • Pharmacologic Substance
Preferred_Name
  • Pergolide Mesylate
NSC_Code
  • 319773
UMLS_CUI
  • C0701027
CAS_Registry
  • 66104-23-2
FDA_UNII_Code
  • 55B9HQY616
Contributing_Source
  • FDA
Chemical_Formula
  • C19H26N2S.CH4O3S
Legacy_Concept_Name
  • Pergolide_Mesylate
CHEBI_ID
  • CHEBI:8021
FULL_SYN
  • 8beta-[(Methylthio)methyl]-6-propylergoline MonomethanesulfonateSNNCI
  • PermaxBRNCI
  • Ergoline, 8-((Methylthio)Methyl)-6-Propyl-, Monomethanesulfonate, (8.Beta.)-SNNCI
  • Pergolide MesylatePTNCI
  • PERGOLIDE MESYLATEPTFDA55B9HQY616
  • LY127809CNNCI
DEFINITION
  • A semi-synthetic ergot derivative and a dopamine agonist with antiparkinson property. Pergolide mesylate binds to and activates dopamine receptor subtypes D1 and D2, resulting in prolactin secretion inhibition, transient increase in serum concentration of growth hormone, and decrease in serum concentration of luteinizing hormone. Direct stimulation of postsynaptic dopamine receptors in the nigrostriatal system, may account for this agent's antiparkinson activity.NCI
code
  • C47665
is Has_Salt_Form of
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 48 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software